Accretion Pharmaceuticals Limited (NSE:ACCPL)
India flag India · Delayed Price · Currency is INR
68.65
+3.20 (4.89%)
At close: Mar 10, 2026

Accretion Pharmaceuticals Company Description

Accretion Pharmaceuticals Limited engages in the manufacturing and marketing of pharmaceutical products in India.

The company offers antibiotic, antibacterial, antifungal, anti-inflammatory, anti-spasmodic, antihistamine, antiallergy, anticough, anticold, antiulcer, gastrointestinal, antacid, anti-diabetic, cardiac, anti-hypertensive, psychotropic, memory enhancer, vitamins, supplements, and other products.

It also provides external preparation, oral powder, effervescent formulation, and nutraceutical products, as well as formulations for brain and memory care, neuron care, UTI care, cardiac care, liver care, protein supplement, pediatric care, GIT care, joint and bone care, immunity booster, gynec care, hair and skin care, nail care, and infertility, and PCOS care.

The company offers its products in the form of tablets, capsules, oral liquid, ointment, cream, gel, lotion, medicated shampoo, mouthwash, dusting powder, sachet, and dry syrup through contract manufacturing and direct sales channels.

It also exports its products to Africa, South-East Asia, and Latin America. Accretion Pharmaceuticals Limited was incorporated in 2012 and is based in Ahmedabad, India.

Accretion Pharmaceuticals Limited
Country India
Founded 2012
Industry Pharmaceutical Preparations
Employees 125
CEO Vivek Ashok Patel

Contact Details

Address:
29 Xcelon Ind Park 1
Ahmedabad, Gujarat 382213
India
Phone 91 97 2375 5277
Website accretionpharma.com

Stock Details

Ticker Symbol ACCPL
Exchange National Stock Exchange of India
Fiscal Year April - March
Reporting Currency INR
SIC Code 2834

Key Executives

Name Position
Vivek Ashok Patel Chief Executive Officer
Harshadbhai Rathod Chief Financial Officer